Optimizing Resource Allocation in United States AIDS Drug Assistance Programs | Zendy

Benjamin P. Linas | Zendy; Hui Zheng | Zendy; Elena Losina | Zendy; Annette Rockwell | Zendy; Rochelle P. Walensky | Zendy; K. Cranston | Zendy; Kenneth A. Freedberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Optimizing Resource Allocation in United States AIDS Drug Assistance Programs

Author(s) -

Benjamin P. Linas,

Hui Zheng,

Elena Losina,

Annette Rockwell,

Rochelle P. Walensky,

K. Cranston,

Kenneth A. Freedberg

Publication year - 2006

Publication title -

clinical infectious diseases

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/508657

Subject(s) - interquartile range , medicine , fiscal year , cohort , demography , family medicine , gerontology , finance , business , sociology

US acquired immunodeficiency syndrome (AIDS) Drug Assistance programs (ADAPs) provide medications to low-income patients with human immunodeficiency virus (HIV) infection/AIDS. Nationally, ADAPs are in a fiscal crisis. Many states have instituted waiting lists, often serving clients on a first-come, first-served basis. We hypothesized that CD4 cell count-based ADAP eligibility would improve ADAP outcomes, allowing them to serve more-diverse patient populations and to prioritize persons who are at greatest risk of HIV-related mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research